LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA – Karyopharm Therapeutics Inc. Transaction History
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA portfolio value:
$2.61M
portfolio value
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA quarter portfolio value change:
+21.06%
quarter
Karyopharm Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.75% | -34.67K shares | 299K | $5.46 | 479.12K |
| Q2 2022 | share | Decrease | -33.79% | -262.25K shares | -3.40M | $4.51 | 513.80K |
| Q1 2022 | share | Decrease | -53.19% | -881.99K shares | -4.94M | $7.37 | 776.05K |
| Q4 2021 | share | Increase | +9.24% | 140.24K shares | 1.82M | $6.72 | 1.65M |
| Q3 2021 | share | Increase | +10.28% | 141.43K shares | -5.37M | $5.82 | 1.51M |
| Q2 2021 | share | Increase | +65.89% | 546.69K shares | 5.47M | $10.32 | 1.37M |
| Q1 2021 | share | Increase | 0.00% | 829.68K shares | 8.72M | $10.52 | 829.68K |